Skip to content

Author

O. Kosmider

We have 3 of 254 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Aug 2026

Integration of clinical and T-cell immune profiling to predict early response to CD3xBCMA bispecific antibody immunotherapy in Multiple Myeloma

It is suggested that integrating clinical and immune parameters measured during the first days of treatment may enable early patient stratification and support the development of a predictive score to identify patients with multiple myeloma who are most likely to benefit from CD3×BCMA BsAb therapy.

Nicolas Deredec, Lisa Aziez, Ismael Boussaid et al. · 0 citations
Aug 2026

Low-frequency CDKN1B variants in pituitary testing: a diagnostic pitfall.

Findings supported a leukocyte-restricted origin of the CDKN1B variants and suggested CHIP as the most likely explanation, but low-frequency CDKN1B variants detected during blood-based germline testing should not be interpreted as constitutional mosaicism or inherited endocrine tumor predisposition.

A. Chansavang, C. Friedrich, Emmanuelle Kuhn et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.